AWE
BSX icon

Avidian Wealth Enterprises’s Boston Scientific BSX Stock Holding History

Avidian Wealth Enterprises’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$371K Buy
8,510
+1,860
+28% +$86.1K 0.01% 551
2026
Q2 		$284K Buy
6,650
+393
+6% +$21.3K 0.01% 610
2026
Q1 		$393K Buy
6,257
+694
+12% +$55.5K 0.01% 487
2025
Q4 		$530K Buy
5,563
+1,727
+45% +$169K 0.02% 359
2025
Q3 		$375K Buy
3,836
+433
+13% +$44.8K 0.01% 425
2025
Q2 		$366K Buy
3,403
+190
+6% +$19.2K 0.01% 402
2025
Q1 		$324K Buy
3,213
+90
+3% +$9.06K 0.01% 397
2024
Q4 		$279K Sell
3,123
-1,590
-34% -$140K 0.01% 415
2024
Q3 		$395K Buy
4,713
+269
+6% +$21.2K 0.02% 340
2024
Q2 		$342K Buy
4,444
+855
+24% +$62.6K 0.01% 366
2024
Q1 		$246K Buy
+3,589
New +$231K 0.01% 388
2022
Q1 		– Sell
-9,018
Closed -$383K – 500
2021
Q4 		$383K Buy
+9,018
New +$379K 0.02% 353

Other funds holding BSX

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
PA
Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Avidian Wealth Enterprises's BSX Position: Q3 2026 in Review

Avidian Wealth Enterprises increased its Boston Scientific (BSX) stake by 28% in Q3 2026, buying an estimated $86.1K and bringing the position to 8,510 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #551.

Avidian Wealth Enterprises first reported a position in BSX in Q4 2021 and has held it in 12 quarters since. The position peaked at $530K in Q4 2025. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Avidian Wealth Enterprises held 8,510 shares of Boston Scientific worth $371K as of Q3 2026.
  • Avidian Wealth Enterprises bought 1,860 Boston Scientific shares in Q3 2026, an estimated $86.1K.
  • Boston Scientific made up 0.01% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #551 holding.
  • Avidian Wealth Enterprises first reported a position in Boston Scientific in Q4 2021 and has held it in 12 quarters since.
  • Avidian Wealth Enterprises's Boston Scientific position peaked at $530K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.